Neurology News

The FDA granted breakthrough device designation to Alpha DaRT for treatment of recurrent glioblastoma multiforme.

In patients with moderate to severe obstructive sleep apnea, carbonic anhydrase inhibition with sulthiame was safe and improved outcomes in the short term, researchers reported at the European Respiratory Society International Congress.

Rituximab and ocrelizumab appeared to increase risk for adverse outcomes among patients with MS and COVID-19, according to study results published in Neurology.

IV thrombolysis appeared safe among patients who had acute ischemic stroke with saccular unruptured intracranial aneurysms, according to results of a prospective cohort study published in Neurology.

While the COVID-19 pandemic has put an incredible burden on all health care workers, it has also fueled a resurgence of anti-Asian racism in the U.S. and highlighted disparities in health care research and opportunities for Asian Americans.

Austedo did not efficaciously treat tics linked to Tourette syndrome in children and adolescents, according to results of a randomized clinical trial published in JAMA Network Open.

Certain ethnic stroke incidence disparities have ended in recent years, according to data from a population-based stroke surveillance study published in Neurology.

Brain and central nervous system tumors are the second most common malignancy among children and the most prevalent form of solid tumor, according to American Cancer Society data.

Clinical nudges, when geared towards increasing the salience of information, providing feedback and implementing default order sets in electronic systems, were “generally effective” in promoting adherence to guidelines, researchers wrote.

Young people with intracranial hypertension had an increased prevalence of disordered eating behaviors, according to study results published in Pediatric Neurology.